Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.32 CHF | +1.97% | +4.94% | +8.78% |
05-10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
05-10 | Novartis Gets FDA Breakthrough Therapy Designation for Scemblix | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.78% | 204B | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
-7.93% | 198B | |
+7.68% | 168B | |
-2.71% | 160B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcript : Novartis AG - Special Call